世界のプロポフォール市場の洞察 : 2029年までの予測

出版：QYResearch（QYリサーチ）　出版年月：2023年3月

Global Propofol Market Insights, Forecast to 2029
世界のプロポフォール市場の洞察 : 2029年までの予測

レポート目次　　お問合せ・ご注文　　価格・納期について

The global Propofol market is projected to grow from US$ 17.70 million in 2023 to US$ 21.85 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.58% during the period of 2023 to 2029.
The global key manufacturers of Propofol include Bachem, Curia, SI Group, Neuland Laboratories, Harman Finochem, Midas Pharma, Guangdong Jiabo Pharmaceutical, Sichuan Biokin Pharmaceutical, Xi’an Libang Pharmaceutical, Beijing Sciecure Pharmaceutical, Jiangsu Nhwa Pharmaceutical, and etc. In 2022, the global top five players had a share approximately 75.46 % in terms of revenue.
In terms of production side, this report researches the Propofol production, growth rate, market share by manufacturers and by region (region level and country level), from 2018 to 2023, and forecast to 2029.
In terms of consumption side, this report focuses on the sales of Propofol by region (region level and country level), by company, by Type and by Application. from 2018 to 2023 and forecast to 2029.
Report Includes:
This report presents an overview of global market for Propofol, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 – 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Propofol, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Propofol, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Propofol sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Propofol market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Propofol sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bachem, Curia, SI Group, Neuland Laboratories, Harman Finochem, Midas Pharma, Guangdong Jiabo Pharmaceutical, Sichuan Biokin Pharmaceutical, Xi’an Libang Pharmaceutical, Beijing Sciecure Pharmaceutical, Jiangsu Nhwa Pharmaceutical, and etc.

By Company
Bachem
Curia
SI Group
Neuland Laboratories
Harman Finochem
Midas Pharma
Guangdong Jiabo Pharmaceutical
Sichuan Biokin Pharmaceutical
Xi’an Libang Pharmaceutical
Beijing Sciecure Pharmaceutical
Jiangsu Nhwa Pharmaceutical

Segment by Type
Purity ≥99.5%
Purity ＜99.5%

Segment by Application
Propofol Injectable Emulsion
Propofol MCT/LCT Injectable Emulsion

Production by Region
North America
Europe
China
India

Sales by Region
US & Canada
U.S.
Canada

China

Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India

Europe
Germany
France
U.K.
Italy
Sweden

Middle East, Africa, Latin America
Brazil
Mexico
GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Propofol production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Propofol in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Propofol manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Propofol sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.

目次

1 Study Coverage 1
1.1 Propofol Product Introduction 1
1.2 Market by Type 1
1.2.1 Global Propofol Market Size by Type, 2018 VS 2022 VS 2029 1
1.2.2 Purity ≥99.5% 2
1.2.3 Purity ＜99.5% 3
1.3 Market by Application 3
1.3.1 Global Propofol Market Size by Application, 2018 VS 2022 VS 2029 3
1.3.2 Propofol Injectable Emulsion 4
1.3.3 Propofol MCT/LCT Injectable Emulsion 4
1.4 Assumptions and Limitations 5
1.5 Study Objectives 6
1.6 Years Considered 7
2 Global Propofol Production 8
2.1 Global Propofol Production Capacity (2018-2029) 8
2.2 Global Propofol Production by Region: 2018 VS 2022 VS 2029 8
2.3 Global Propofol Production by Region 10
2.3.1 Global Propofol Historic Production by Region (2018-2023) 10
2.3.2 Global Propofol Forecasted Production by Region (2024-2029) 10
2.3.3 Global Propofol Production Market Share by Region (2018-2029) 11
2.4 North America 12
2.5 Europe 13
2.6 China 14
2.7 India 15
3 Executive Summary 16
3.1 Global Propofol Revenue Estimates and Forecasts 2018-2029 16
3.2 Global Propofol Revenue by Region 17
3.2.1 Global Propofol Revenue by Region: 2018 VS 2022 VS 2029 17
3.2.2 Global Propofol Revenue by Region (2018-2023) 19
3.2.3 Global Propofol Revenue by Region (2024-2029) 19
3.2.4 Global Propofol Revenue Market Share by Region (2018-2029) 20
3.3 Global Propofol Sales Estimates and Forecasts 2018-2029 21
3.4 Global Propofol Sales by Region 22
3.4.1 Global Propofol Sales by Region: 2018 VS 2022 VS 2029 22
3.4.2 Global Propofol Sales by Region (2018-2023) 23
3.4.3 Global Propofol Sales by Region (2024-2029) 23
3.4.4 Global Propofol Sales Market Share by Region (2018-2029) 23
3.5 US & Canada 25
3.6 Europe 27
3.7 China 29
3.8 Asia (excluding China) 31
3.9 Middle East, Africa and Latin America 33
4 Competition by Manufacturers 35
4.1 Global Propofol Sales by Manufacturers 35
4.1.1 Global Propofol Sales by Manufacturers (2018-2023) 35
4.1.2 Global Propofol Sales Market Share by Manufacturers (2018-2023) 36
4.1.3 Global Top 3 and Top 5 Largest Manufacturers of Propofol in 2022 36
4.2 Global Propofol Revenue by Manufacturers 37
4.2.1 Global Propofol Revenue by Manufacturers (2018-2023) 37
4.2.2 Global Propofol Revenue Market Share by Manufacturers (2018-2023) 38
4.2.3 Global Top 3 and Top 5 Companies by Propofol Revenue in 2022 39
4.3 Global Propofol Sales Price by Manufacturers (2018-2023) 40
4.4 Global Key Players of Propofol, Industry Ranking, 2021 VS 2022 41
4.5 Analysis of Competitive Landscape 41
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 41
4.5.2 Global Propofol Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 42
4.6 Global Key Manufacturers of Propofol, Manufacturing Base Distribution and Headquarters 43
4.7 Found Date of Global Key Manufacturers of Propofol 43
4.8 Mergers & Acquisitions, Expansion Plans 44
5 Market Size by Type 45
5.1 Global Propofol Sales by Type 45
5.1.1 Global Propofol Historical Sales by Type (2018-2023) 45
5.1.2 Global Propofol Forecasted Sales by Type (2024-2029) 45
5.1.3 Global Propofol Sales Market Share by Type (2018-2029) 45
5.2 Global Propofol Revenue by Type 46
5.2.1 Global Propofol Historical Revenue by Type (2018-2023) 46
5.2.2 Global Propofol Forecasted Revenue by Type (2024-2029) 47
5.2.3 Global Propofol Revenue Market Share by Type (2018-2029) 47
5.3 Global Propofol Price by Type 48
5.3.1 Global Propofol Price by Type (2018-2023) 48
5.3.2 Global Propofol Price Forecast by Type (2024-2029) 48
6 Market Size by Application 49
6.1 Global Propofol Sales by Application 49
6.1.1 Global Propofol Historical Sales by Application (2018-2023) 49
6.1.2 Global Propofol Forecasted Sales by Application (2024-2029) 49
6.1.3 Global Propofol Sales Market Share by Application (2018-2029) 49
6.2 Global Propofol Revenue by Application 50
6.2.1 Global Propofol Historical Revenue by Application (2018-2023) 50
6.2.2 Global Propofol Forecasted Revenue by Application (2024-2029) 51
6.2.3 Global Propofol Revenue Market Share by Application (2018-2029) 51
6.3 Global Propofol Price by Application 52
6.3.1 Global Propofol Price by Application (2018-2023) 52
6.3.2 Global Propofol Price Forecast by Application (2024-2029) 52
7 US & Canada 53
7.1 US & Canada Propofol Market Size by Type 53
7.1.1 US & Canada Propofol Sales by Type (2018-2029) 53
7.1.2 US & Canada Propofol Revenue by Type (2018-2029) 54
7.2 US & Canada Propofol Market Size by Application 55
7.2.1 US & Canada Propofol Sales by Application (2018-2029) 55
7.2.2 US & Canada Propofol Revenue by Application (2018-2029) 56
7.3 US & Canada Propofol Market Size by Country 57
7.3.1 US & Canada Propofol Revenue by Country: 2018 VS 2022 VS 2029 57
7.3.2 US & Canada Propofol Revenue by Country (2018-2029) 58
7.3.3 US & Canada Propofol Sales by Country (2018-2029) 59
7.3.4 US 61
7.3.5 Canada 62
8 Europe 63
8.1 Europe Propofol Market Size by Type 63
8.1.1 Europe Propofol Sales by Type (2018-2029) 63
8.1.2 Europe Propofol Revenue by Type (2018-2029) 64
8.2 Europe Propofol Market Size by Application 65
8.2.1 Europe Propofol Sales by Application (2018-2029) 65
8.2.2 Europe Propofol Revenue by Application (2018-2029) 66
8.3 Europe Propofol Market Size by Country 68
8.3.1 Europe Propofol Revenue by Country: 2018 VS 2022 VS 2029 68
8.3.2 Europe Propofol Sales by Country (2018-2029) 68
8.3.3 Europe Propofol Revenue by Country (2018-2029) 70
8.3.4 Germany 72
8.3.5 France 73
8.3.6 U.K. 74
8.3.7 Italy 75
8.3.8 Sweden 76
9 China 77
9.1 China Propofol Market Size by Type 77
9.1.1 China Propofol Sales by Type (2018-2029) 77
9.1.2 China Propofol Revenue by Type (2018-2029) 78
9.2 China Propofol Market Size by Application 79
9.2.1 China Propofol Sales by Application (2018-2029) 79
9.2.2 China Propofol Revenue by Application (2018-2029) 80
10 Asia (excluding China) 82
10.1 Asia Propofol Market Size by Type 82
10.1.1 Asia Propofol Sales by Type (2018-2029) 82
10.1.2 Asia Propofol Revenue by Type (2018-2029) 83
10.2 Asia Propofol Market Size by Application 84
10.2.1 Asia Propofol Sales by Application (2018-2029) 84
10.2.2 Asia Propofol Revenue by Application (2018-2029) 85
10.3 Asia Propofol Market Size by Region 87
10.3.1 Asia Propofol Revenue by Region: 2018 VS 2022 VS 2029 87
10.3.2 Asia Propofol Revenue by Region (2018-2029) 87
10.3.3 Asia Propofol Sales by Region (2018-2029) 88
10.3.4 Japan 91
10.3.5 South Korea 92
10.3.6 China Taiwan 93
10.3.7 India 94
11 Middle East, Africa and Latin America 95
11.1 Middle East, Africa and Latin America Propofol Market Size by Type 95
11.1.1 Middle East, Africa and Latin America Propofol Sales by Type (2018-2029) 95
11.1.2 Middle East, Africa and Latin America Propofol Revenue by Type (2018-2029) 96
11.2 Middle East, Africa and Latin America Propofol Market Size by Application 98
11.2.1 Middle East, Africa and Latin America Propofol Sales by Application (2018-2029) 98
11.2.2 Middle East, Africa and Latin America Propofol Revenue by Application (2018-2029) 99
11.3 Middle East, Africa and Latin America Propofol Market Size by Country 101
11.3.1 Middle East, Africa and Latin America Propofol Revenue by Country: 2018 VS 2022 VS 2029 101
11.3.2 Middle East, Africa and Latin America Propofol Revenue by Country (2018-2029) 101
11.3.3 Middle East, Africa and Latin America Propofol Sales by Country (2018-2029) 103
11.3.4 Brazil 105
11.3.5 Mexico 106
11.3.6 GCC Countries 107
12 Corporate Profile 108
12.1 Bachem 108
12.1.1 Bachem Corporation Information 108
12.1.2 Bachem Overview 109
12.1.3 Bachem Propofol Capacity, Sales, Price, Revenue and Gross Margin (2018-2023) 109
12.1.4 Bachem Propofol Product Model Numbers, Pictures, Descriptions and Specifications 110
12.1.5 Bachem Recent Developments 111
12.2 Curia 111
12.2.1 Curia Corporation Information 111
12.2.2 Curia Overview 112
12.2.3 Curia Propofol Capacity, Sales, Price, Revenue and Gross Margin (2018-2023) 112
12.2.4 Curia Propofol Product Model Numbers, Pictures, Descriptions and Specifications 113
12.2.5 Curia Recent Developments 113
12.3 SI Group 113
12.3.1 SI Group Corporation Information 114
12.3.2 SI Group Overview 114
12.3.3 SI Group Propofol Capacity, Sales, Price, Revenue and Gross Margin (2018-2023) 115
12.3.4 SI Group Propofol Product Model Numbers, Pictures, Descriptions and Specifications 115
12.3.5 SI Group Recent Developments 115
12.4 Neuland Laboratories 116
12.4.1 Neuland Laboratories Corporation Information 116
12.4.2 Neuland Laboratories Overview 117
12.4.3 Neuland Laboratories Propofol Capacity, Sales, Price, Revenue and Gross Margin (2018-2023) 117
12.4.4 Neuland Laboratories Propofol Product Model Numbers, Pictures, Descriptions and Specifications 118
12.5 Harman Finochem 118
12.5.1 Harman Finochem Corporation Information 118
12.5.2 Harman Finochem Overview 119
12.5.3 Harman Finochem Propofol Capacity, Sales, Price, Revenue and Gross Margin (2018-2023) 120
12.5.4 Harman Finochem Propofol Product Model Numbers, Pictures, Descriptions and Specifications 120
12.6 Midas Pharma 121
12.6.1 Midas Pharma Corporation Information 121
12.6.2 Midas Pharma Overview 121
12.6.3 Midas Pharma Propofol Capacity, Sales, Price, Revenue and Gross Margin (2018-2023) 122
12.6.4 Midas Pharma Propofol Product Model Numbers, Pictures, Descriptions and Specifications 122
12.6.5 Midas Pharma Recent Developments 123
12.7 Guangdong Jiabo Pharmaceutical 123
12.7.1 Guangdong Jiabo Pharmaceutical Corporation Information 124
12.7.2 Guangdong Jiabo Pharmaceutical Overview 124
12.7.3 Guangdong Jiabo Pharmaceutical Propofol Capacity, Sales, Price, Revenue and Gross Margin (2018-2023) 125
12.7.4 Guangdong Jiabo Pharmaceutical Propofol Product Model Numbers, Pictures, Descriptions and Specifications 125
12.7.5 Guangdong Jiabo Pharmaceutical Recent Developments 126
12.8 Sichuan Biokin Pharmaceutical 126
12.8.1 Sichuan Biokin Pharmaceutical Corporation Information 126
12.8.2 Sichuan Biokin Pharmaceutical Overview 127
12.8.3 Sichuan Biokin Pharmaceutical Propofol Capacity, Sales, Price, Revenue and Gross Margin (2018-2023) 127
12.8.4 Sichuan Biokin Pharmaceutical Propofol Product Model Numbers, Pictures, Descriptions and Specifications 128
12.8.5 Sichuan Biokin Pharmaceutical Recent Developments 128
12.9 Xi鈥檃n Libang Pharmaceutical 128
12.9.1 Xi鈥檃n Libang Pharmaceutical Corporation Information 129
12.9.2 Xi鈥檃n Libang Pharmaceutical Overview 129
12.9.3 Xi鈥檃n Libang Pharmaceutical Propofol Capacity, Sales, Price, Revenue and Gross Margin (2018-2023) 130
12.9.4 Xi鈥檃n Libang Pharmaceutical Propofol Product Model Numbers, Pictures, Descriptions and Specifications 130
12.9.5 Xi鈥檃n Libang Pharmaceutical Recent Developments 130
12.10 Beijing Sciecure Pharmaceutical 131
12.10.1 Beijing Sciecure Pharmaceutical Corporation Information 131
12.10.2 Beijing Sciecure Pharmaceutical Overview 132
12.10.3 Beijing Sciecure Pharmaceutical Propofol Capacity, Sales, Price, Revenue and Gross Margin (2018-2023) 132
12.10.4 Beijing Sciecure Pharmaceutical Propofol Product Model Numbers, Pictures, Descriptions and Specifications 133
12.10.5 Beijing Sciecure Pharmaceutical Recent Developments 133
12.11 Jiangsu Nhwa Pharmaceutical 133
12.11.1 Jiangsu Nhwa Pharmaceutical Corporation Information 133
12.11.2 Jiangsu Nhwa Pharmaceutical Overview 134
12.11.3 Jiangsu Nhwa Pharmaceutical Propofol Capacity, Sales, Price, Revenue and Gross Margin (2018-2023) 135
12.11.4 Jiangsu Nhwa Pharmaceutical Propofol Product Model Numbers, Pictures, Descriptions and Specifications 135
12.11.5 Jiangsu Nhwa Pharmaceutical Recent Developments 135
13 Industry Chain and Sales Channels Analysis 137
13.1 Propofol Industry Chain Analysis 137
13.2 Propofol Key Raw Materials 137
13.2.1 Key Raw Materials 137
13.2.2 Raw Materials Key Suppliers 138
13.3 Propofol Production Mode & Process 138
13.4 Propofol Sales and Marketing 139
13.4.1 Propofol Sales Channels 139
13.4.2 Propofol Distributors 139
13.5 Propofol Customers 140
14 Propofol Market Dynamics 141
14.1.1 Propofol Industry Trends 141
14.1.2 Propofol Market Drivers 141
14.1.3 Propofol Market Challenges 142
14.1.4 Propofol Market Restraints 142
15 Key Findings in the Global Propofol Study 143
16 Appendix 144
16.1 Research Methodology 144
16.1.1 Methodology/Research Approach 144
16.1.2 Data Source 148
16.2 Author Details 151
16.3 Disclaimer 154

Table 1. Global Propofol Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (K USD) 1
Table 2. Global Propofol Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (K USD) 3
Table 3. Global Propofol Production Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (MT) 8
Table 4. Global Propofol Production by Region (2018-2023) & (MT) 10
Table 5. Global Propofol Production by Region (2024-2029) & (MT) 10
Table 6. Global Propofol Production Market Share by Region (2018-2023) 11
Table 7. Global Propofol Production Market Share by Region (2024-2029) 11
Table 8. Global Propofol Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (K USD) 18
Table 9. Global Propofol Revenue by Region (2018-2023) & (K USD) 19
Table 10. Global Propofol Revenue by Region (2024-2029) & (K USD) 19
Table 11. Global Propofol Revenue Market Share by Region (2018-2023) 20
Table 12. Global Propofol Revenue Market Share by Region (2024-2029) 20
Table 13. Global Propofol Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (MT) 22
Table 14. Global Propofol Sales by Region (2018-2023) & (MT) 23
Table 15. Global Propofol Sales by Region (2024-2029) & (MT) 23
Table 16. Global Propofol Sales Market Share by Region (2018-2023) 23
Table 17. Global Propofol Sales Market Share by Region (2024-2029) 24
Table 18. Global Propofol Sales by Manufacturers (2018-2023) & (MT) 35
Table 19. Global Propofol Sales Share by Manufacturers (2018-2023) 36
Table 20. Global Propofol Revenue by Manufacturers (2018-2023) & (K USD) 38
Table 21. Global Propofol Revenue Market Share by Manufacturers (2018-2023) 38
Table 22. Propofol Price by Manufacturers (2018-2023) & (USD/Kg) 40
Table 23. Global Key Players of Propofol, Industry Ranking, 2021 VS 2022 41
Table 24. Global Propofol Manufacturers Market Concentration Ratio (CR5 and HHI) 42
Table 25. Global Propofol by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Propofol as of 2022) 42
Table 26. Global Key Manufacturers of Propofol, Manufacturing Base Distribution and Headquarters 43
Table 27. Found Date of Global Key Manufacturers of Propofol 43
Table 28. Mergers & Acquisitions, Expansion Plans 44
Table 29. Global Propofol Sales by Type (2018-2023) & (MT) 45
Table 30. Global Propofol Sales by Type (2024-2029) & (MT) 45
Table 31. Global Propofol Sales Share by Type (2018-2023) 45
Table 32. Global Propofol Sales Share by Type (2024-2029) 46
Table 33. Global Propofol Revenue by Type (2018-2023) & (K USD) 46
Table 34. Global Propofol Revenue by Type (2024-2029) & (K USD) 47
Table 35. Global Propofol Revenue Share by Type (2018-2023) 47
Table 36. Global Propofol Revenue Share by Type (2024-2029) 47
Table 37. Propofol Price by Type (2018-2023) & (USD/Kg) 48
Table 38. Global Propofol Price Forecast by Type (2024-2029) & (USD/Kg) 48
Table 39. Global Propofol Sales by Application (2018-2023) & (MT) 49
Table 40. Global Propofol Sales by Application (2024-2029) & (MT) 49
Table 41. Global Propofol Sales Share by Application (2018-2023) 49
Table 42. Global Propofol Sales Share by Application (2024-2029) 50
Table 43. Global Propofol Revenue by Application (2018-2023) & (K USD) 50
Table 44. Global Propofol Revenue by Application (2024-2029) & (K USD) 51
Table 45. Global Propofol Revenue Share by Application (2018-2023) 51
Table 46. Global Propofol Revenue Share by Application (2024-2029) 51
Table 47. Propofol Price by Application (2018-2023) & (USD/Kg) 52
Table 48. Global Propofol Price Forecast by Application (2024-2029) & (USD/Kg) 52
Table 49. US & Canada Propofol Sales by Type (2018-2023) & (MT) 53
Table 50. US & Canada Propofol Sales by Type (2024-2029) & (MT) 53
Table 51. US & Canada Propofol Revenue by Type (2018-2023) & (K USD) 54
Table 52. US & Canada Propofol Revenue by Type (2024-2029) & (K USD) 54
Table 53. US & Canada Propofol Sales by Application (2018-2023) & (MT) 55
Table 54. US & Canada Propofol Sales by Application (2024-2029) & (MT) 55
Table 55. US & Canada Propofol Revenue by Application (2018-2023) & (K USD) 56
Table 56. US & Canada Propofol Revenue by Application (2024-2029) & (K USD) 57
Table 57. US & Canada Propofol Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (K USD) 57
Table 58. US & Canada Propofol Revenue by Country (2018-2023) & (K USD) 58
Table 59. US & Canada Propofol Revenue by Country (2024-2029) & (K USD) 58
Table 60. US & Canada Propofol Sales by Country (2018-2023) & (MT) 59
Table 61. US & Canada Propofol Sales by Country (2024-2029) & (MT) 59
Table 62. Europe Propofol Sales by Type (2018-2023) & (MT) 63
Table 63. Europe Propofol Sales by Type (2024-2029) & (MT) 63
Table 64. Europe Propofol Revenue by Type (2018-2023) & (K USD) 64
Table 65. Europe Propofol Revenue by Type (2024-2029) & (K USD) 64
Table 66. Europe Propofol Sales by Application (2018-2023) & (MT) 65
Table 67. Europe Propofol Sales by Application (2024-2029) & (MT) 66
Table 68. Europe Propofol Revenue by Application (2018-2023) & (K USD) 66
Table 69. Europe Propofol Revenue by Application (2024-2029) & (K USD) 67
Table 70. Europe Propofol Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (K USD) 68
Table 71. Europe Propofol Sales by Country (2018-2023) & (MT) 68
Table 72. Europe Propofol Sales by Country (2024-2029) & (MT) 69
Table 73. Europe Propofol Revenue by Country (2018-2023) & (K USD) 70
Table 74. Europe Propofol Revenue by Country (2024-2029) & (K USD) 70
Table 75. China Propofol Sales by Type (2018-2023) & (MT) 77
Table 76. China Propofol Sales by Type (2024-2029) & (MT) 77
Table 77. China Propofol Revenue by Type (2018-2023) & (K USD) 78
Table 78. China Propofol Revenue by Type (2024-2029) & (K USD) 78
Table 79. China Propofol Sales by Application (2018-2023) & (MT) 79
Table 80. China Propofol Sales by Application (2024-2029) & (MT) 79
Table 81. China Propofol Revenue by Application (2018-2023) & (K USD) 80
Table 82. China Propofol Revenue by Application (2024-2029) & (K USD) 81
Table 83. Asia Propofol Sales by Type (2018-2023) & (MT) 82
Table 84. Asia Propofol Sales by Type (2024-2029) & (MT) 82
Table 85. Asia Propofol Revenue by Type (2018-2023) & (K USD) 83
Table 86. Asia Propofol Revenue by Type (2024-2029) & (K USD) 83
Table 87. Asia Propofol Sales by Application (2018-2023) & (MT) 84
Table 88. Asia Propofol Sales by Application (2024-2029) & (MT) 85
Table 89. Asia Propofol Revenue by Application (2018-2023) & (K USD) 85
Table 90. Asia Propofol Revenue by Application (2024-2029) & (K USD) 86
Table 91. Asia Propofol Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (K USD) 87
Table 92. Asia Propofol Revenue by Region (2018-2023) & (K USD) 87
Table 93. Asia Propofol Revenue by Region (2024-2029) & (K USD) 87
Table 94. Asia Propofol Sales by Region (2018-2023) & (MT) 88
Table 95. Asia Propofol Sales by Region (2024-2029) & (MT) 89
Table 96. Middle East, Africa and Latin America Propofol Sales by Type (2018-2023) & (MT) 95
Table 97. Middle East, Africa and Latin America Propofol Sales by Type (2024-2029) & (MT) 95
Table 98. Middle East, Africa and Latin America Propofol Revenue by Type (2018-2023) & (K USD) 96
Table 99. Middle East, Africa and Latin America Propofol Revenue by Type (2024-2029) & (K USD) 96
Table 100. Middle East, Africa and Latin America Propofol Sales by Application (2018-2023) & (MT) 98
Table 101. Middle East, Africa and Latin America Propofol Sales by Application (2024-2029) & (MT) 98
Table 102. Middle East, Africa and Latin America Propofol Revenue by Application (2018-2023) & (K USD) 99
Table 103. Middle East, Africa and Latin America Propofol Revenue by Application (2024-2029) & (K USD) 100
Table 104. Middle East, Africa and Latin America Propofol Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (K USD) 101
Table 105. Middle East, Africa and Latin America Propofol Revenue by Country (2018-2023) & (K USD) 101
Table 106. Middle East, Africa and Latin America Propofol Revenue by Country (2024-2029) & (K USD) 102
Table 107. Middle East, Africa and Latin America Propofol Sales by Country (2018-2023) & (MT) 103
Table 108. Middle East, Africa and Latin America Propofol Sales by Country (2024-2029) & (MT) 103
Table 109. Bachem Corporation Information 108
Table 110. Bachem Description and Major Businesses 109
Table 111. Bachem Propofol Capacity, Sales (MT), Revenue (K USD), Price (USD/Kg) and Gross Margin (2018-2023) 109
Table 112. Bachem Propofol Product Model Numbers, Pictures, Descriptions and Specifications 110
Table 113. Bachem Recent Developments 111
Table 114. Curia Corporation Information 111
Table 115. Curia Description and Major Businesses 112
Table 116. Curia Propofol Capacity, Sales (MT), Revenue (K USD), Price (USD/Kg) and Gross Margin (2018-2023) 112
Table 117. Curia Propofol Product Model Numbers, Pictures, Descriptions and Specifications 113
Table 118. Curia Recent Developments 113
Table 119. SI Group Corporation Information 114
Table 120. SI Group Description and Major Businesses 114
Table 121. SI Group Propofol Capacity, Sales (MT), Revenue (K USD), Price (USD/Kg) and Gross Margin (2018-2023) 115
Table 122. SI Group Propofol Product Model Numbers, Pictures, Descriptions and Specifications 115
Table 123. SI Group Recent Developments 115
Table 124. Neuland Laboratories Corporation Information 116
Table 125. Neuland Laboratories Description and Major Businesses 117
Table 126. Neuland Laboratories Propofol Capacity, Sales (MT), Revenue (K USD), Price (USD/Kg) and Gross Margin (2018-2023) 117
Table 127. Neuland Laboratories Propofol Product Model Numbers, Pictures, Descriptions and Specifications 118
Table 128. Harman Finochem Corporation Information 118
Table 129. Harman Finochem Description and Major Businesses 119
Table 130. Harman Finochem Propofol Capacity, Sales (MT), Revenue (K USD), Price (USD/Kg) and Gross Margin (2018-2023) 120
Table 131. Harman Finochem Propofol Product Model Numbers, Pictures, Descriptions and Specifications 120
Table 132. Midas Pharma Corporation Information 121
Table 133. Midas Pharma Description and Major Businesses 121
Table 134. Midas Pharma Propofol Capacity, Sales (MT), Revenue (K USD), Price (USD/Kg) and Gross Margin (2018-2023) 122
Table 135. Midas Pharma Propofol Product Model Numbers, Pictures, Descriptions and Specifications 122
Table 136. Midas Pharma Recent Developments 123
Table 137. Guangdong Jiabo Pharmaceutical Corporation Information 124
Table 138. Guangdong Jiabo Pharmaceutical Description and Major Businesses 124
Table 139. Guangdong Jiabo Pharmaceutical Propofol Capacity, Sales (MT), Revenue (K USD), Price (USD/Kg) and Gross Margin (2018-2023) 125
Table 140. Guangdong Jiabo Pharmaceutical Propofol Product Model Numbers, Pictures, Descriptions and Specifications 125
Table 141. Guangdong Jiabo Pharmaceutical Recent Developments 126
Table 142. Sichuan Biokin Pharmaceutical Corporation Information 126
Table 143. Sichuan Biokin Pharmaceutical Description and Major Businesses 127
Table 144. Sichuan Biokin Pharmaceutical Propofol Capacity, Sales (MT), Revenue (K USD), Price (USD/Kg) and Gross Margin (2018-2023) 127
Table 145. Sichuan Biokin Pharmaceutical Propofol Product Model Numbers, Pictures, Descriptions and Specifications 128
Table 146. Sichuan Biokin Pharmaceutical Recent Developments 128
Table 147. Xi鈥檃n Libang Pharmaceutical Corporation Information 129
Table 148. Xi鈥檃n Libang Pharmaceutical Description and Major Businesses 129
Table 149. Xi鈥檃n Libang Pharmaceutical Propofol Capacity, Sales (MT), Revenue (K USD), Price (USD/Kg) and Gross Margin (2018-2023) 130
Table 150. Xi鈥檃n Libang Pharmaceutical Propofol Product Model Numbers, Pictures, Descriptions and Specifications 130
Table 151. Xi鈥檃n Libang Pharmaceutical Recent Developments 130
Table 152. Beijing Sciecure Pharmaceutical Corporation Information 131
Table 153. Beijing Sciecure Pharmaceutical Description and Major Businesses 132
Table 154. Beijing Sciecure Pharmaceutical Propofol Capacity, Sales (MT), Revenue (K USD), Price (USD/Kg) and Gross Margin (2018-2023) 132
Table 155. Beijing Sciecure Pharmaceutical Propofol Product Model Numbers, Pictures, Descriptions and Specifications 133
Table 156. Beijing Sciecure Pharmaceutical Recent Developments 133
Table 157. Jiangsu Nhwa Pharmaceutical Corporation Information 133
Table 158. Jiangsu Nhwa Pharmaceutical Description and Major Businesses 134
Table 159. Jiangsu Nhwa Pharmaceutical Propofol Capacity, Sales (MT), Revenue (K USD), Price (USD/Kg) and Gross Margin (2018-2023) 135
Table 160. Jiangsu Nhwa Pharmaceutical Propofol Product Model Numbers, Pictures, Descriptions and Specifications 135
Table 161. Jiangsu Nhwa Pharmaceutical Recent Developments 135
Table 162. Raw Materials Key Suppliers Lists 138
Table 163. Propofol Distributors List 139
Table 164. Propofol Customers List 140
Table 165. Propofol Market Trends 141
Table 166. Propofol Market Challenges 142
Table 167. Research Programs/Design for This Report 144
Table 168. Key Data Information from Secondary Sources 149
Table 169. Key Data Information from Primary Sources 150
Table 170. QYR Business Unit and Senior & Team Lead Analysts 152

List of Figures

Figure 1. Propofol Product Picture 1
Figure 2. Global Propofol Market Share by Type: 2022 & 2029 2
Figure 3. Global Propofol Market Share by Application in 2022 & 2029 4
Figure 4. Propofol Injectable Emulsion 4
Figure 5. Propofol MCT/LCT Injectable Emulsion 5
Figure 6. Propofol Report Years Considered 7
Figure 7. Global Propofol Capacity, Production and Utilization (2018-2029) & (MT) 8
Figure 8. Global Propofol Production Market Share by Region in Percentage: 2022 Versus 2029 9
Figure 9. Global Propofol Production Market Share by Region (2018-2029) 12
Figure 10. Propofol Production Growth Rate in North America (2018-2029) & (MT) 12
Figure 11. Propofol Production Growth Rate in Europe (2018-2029) & (MT) 13
Figure 12. Propofol Production Growth Rate in China (2018-2029) & (MT) 14
Figure 13. Propofol Production Growth Rate in India (2018-2029) & (MT) 15
Figure 14. Global Propofol Revenue, (K USD), 2018 VS 2022 VS 2029 16
Figure 15. Global Propofol Revenue 2018-2029 (K USD) 17
Figure 16. Global Propofol Revenue Market Share by Region in Percentage: 2022 Versus 2029 18
Figure 17. Global Propofol Revenue Market Share by Region (2018-2029) 21
Figure 18. Global Propofol Sales 2018-2029 (MT) 22
Figure 19. Global Propofol Sales Market Share by Region (2018-2029) 24
Figure 20. US & Canada Propofol Sales YoY (2018-2029) & (MT) 25
Figure 21. US & Canada Propofol Revenue YoY (2018-2029) & (K USD) 26
Figure 22. Europe Propofol Sales YoY (2018-2029) & (MT) 27
Figure 23. Europe Propofol Revenue YoY (2018-2029) & (K USD) 28
Figure 24. China Propofol Sales YoY (2018-2029) & (MT) 29
Figure 25. China Propofol Revenue YoY (2018-2029) & (K USD) 30
Figure 26. Asia (excluding China) Propofol Sales YoY (2018-2029) & (MT) 31
Figure 27. Asia (excluding China) Propofol Revenue YoY (2018-2029) & (K USD) 32
Figure 28. Middle East, Africa and Latin America Propofol Sales YoY (2018-2029) & (MT) 33
Figure 29. Middle East, Africa and Latin America Propofol Revenue YoY (2018-2029) & (K USD) 34
Figure 30. The Propofol Market Share of Top 3 and Top 5 Largest Manufacturers Around the World in 2022 37
Figure 31. The Top 3 and 5 Largest Manufacturers of Propofol in the World: Market Share by Propofol Revenue in 2022 39
Figure 32. Global Propofol Sales Market Share by Type (2018-2029) 46
Figure 33. Global Propofol Revenue Market Share by Type (2018-2029) 48
Figure 34. Global Propofol Sales Market Share by Application (2018-2029) 50
Figure 35. Global Propofol Revenue Market Share by Application (2018-2029) 52
Figure 36. US & Canada Propofol Sales Market Share by Type (2018-2029) 54
Figure 37. US & Canada Propofol Revenue Market Share by Type (2018-2029) 55
Figure 38. US & Canada Propofol Sales Market Share by Application (2018-2029) 56
Figure 39. US & Canada Propofol Revenue Market Share by Application (2018-2029) 57
Figure 40. US & Canada Propofol Revenue Share by Country (2018-2029) 59
Figure 41. US & Canada Propofol Sales Share by Country (2018-2029) 60
Figure 42. US Propofol Revenue (2018-2029) & (K USD) 61
Figure 43. Canada Propofol Revenue (2018-2029) & (K USD) 62
Figure 44. Europe Propofol Sales Market Share by Type (2018-2029) 64
Figure 45. Europe Propofol Revenue Market Share by Type (2018-2029) 65
Figure 46. Europe Propofol Sales Market Share by Application (2018-2029) 66
Figure 47. Europe Propofol Revenue Market Share by Application (2018-2029) 67
Figure 48. Europe Propofol Sales Share by Country (2018-2029) 69
Figure 49. Europe Propofol Revenue Share by Country (2018-2029) 71
Figure 50. Germany Propofol Revenue (2018-2029) & (K USD) 72
Figure 51. France Propofol Revenue (2018-2029) & (K USD) 73
Figure 52. U.K. Propofol Revenue (2018-2029) & (K USD) 74
Figure 53. Italy Propofol Revenue (2018-2029) & (K USD) 75
Figure 54. Sweden Propofol Revenue (2018-2029) & (K USD) 76
Figure 55. China Propofol Sales Market Share by Type (2018-2029) 78
Figure 56. China Propofol Revenue Market Share by Type (2018-2029) 79
Figure 57. China Propofol Sales Market Share by Application (2018-2029) 80
Figure 58. China Propofol Revenue Market Share by Application (2018-2029) 81
Figure 59. Asia Propofol Sales Market Share by Type (2018-2029) 83
Figure 60. Asia Propofol Revenue Market Share by Type (2018-2029) 84
Figure 61. Asia Propofol Sales Market Share by Application (2018-2029) 85
Figure 62. Asia Propofol Revenue Market Share by Application (2018-2029) 86
Figure 63. Asia Propofol Revenue Share by Region (2018-2029) 88
Figure 64. Asia Propofol Sales Share by Region (2018-2029) 90
Figure 65. Japan Propofol Revenue (2018-2029) & (K USD) 91
Figure 66. South Korea Propofol Revenue (2018-2029) & (K USD) 92
Figure 67. China Taiwan Propofol Revenue (2018-2029) & (K USD) 93
Figure 68. India Propofol Revenue (2018-2029) & (K USD) 94
Figure 69. Middle East, Africa and Latin America Propofol Sales Market Share by Type (2018-2029) 96
Figure 70. Middle East, Africa and Latin America Propofol Revenue Market Share by Type (2018-2029) 97
Figure 71. Middle East, Africa and Latin America Propofol Sales Market Share by Application (2018-2029) 99
Figure 72. Middle East, Africa and Latin America Propofol Revenue Market Share by Application (2018-2029) 100
Figure 73. Middle East, Africa and Latin America Propofol Revenue Share by Country (2018-2029) 102
Figure 74. Middle East, Africa and Latin America Propofol Sales Share by Country (2018-2029) 104
Figure 75. Brazil Propofol Revenue (2018-2029) & (K USD) 105
Figure 76. Mexico Propofol Revenue (2018-2029) & (K USD) 106
Figure 77. GCC Countries Propofol Revenue (2018-2029) & (K USD) 107
Figure 78. Propofol Value Chain 137
Figure 79. Propofol Production Process 138
Figure 80. Bottom-up and Top-down Approaches for This Report 147
Figure 81. Data Triangulation 148
Figure 82. Key Executives Interviewed 151